Edgar C. Kisby v. HHS - Tdap, Guillain-Barre Syndrome (2018)

Filed 2017-11-19Decided 2018-12-14Vaccine Tdap
compensated$81,651

Case summary [AI summaries can sometimes make mistakes]

Edgar C. Kisby filed a petition for compensation under the National Vaccine Injury Compensation Program on August 22, 2017, alleging he developed Guillain-Barre Syndrome (GBS) after receiving a Tetanus-Diphtheria-Acellular Pertussis (Tdap) vaccine on August 16, 2016.

The respondent, the Secretary of Health and Human Services, denied that the immunization caused petitioner's injury. The parties reached a settlement, agreeing that the respondent would issue a payment of $81,650.77 to Mr.

Kisby as compensation for all damages. Special Master Mindy Michaels Roth adopted the parties' stipulation and awarded the compensation.

The decision was issued on December 14, 2018. The public decision does not describe the specific onset of symptoms, clinical details, or expert testimony.

Theory of causation

Petitioner Edgar C. Kisby alleged Guillain-Barre Syndrome (GBS) following a Tdap vaccination on August 16, 2016. The respondent denied causation. The parties stipulated to a settlement. The Special Master adopted the stipulation. The award was $81,650.77. The public decision does not detail the specific theory of causation, expert testimony, or the mechanism of injury.

Source PDFs 2 total · 1 downloaded